Secukinumab Biosimilar - Research Grade
Product Specifications
Background
Secukinumab is a recombinant human monoclonal IgG1/κ antibody that binds specifically to IL-17A. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Secukinumab has a molecular mass of approximately 151 kDa; both heavy chains of secukinumab contain oligosaccharide chains.
Specifications
Detects human IL17A. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Secukinumab.
Product Name Alternative
Interleukin-17A, IL17A, CTLA-8, CTLA8
UniProt
Q16552
Host
Humanized
Species Reactivity
Human
Target
IL17A
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100mL ICH3002-100mL ICH3003-100mL
Shipping Conditions
Blue ice
Storage Conditions
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Anti-AKT1/2/3 Antibody [ST48-09]](https://cdn.genprice.uk/products/992/68dd1c90061270361ea82c24/imageurl01/et1609-51tr.webp)
